Inventor · disambiguated record
Metin Kurtoglu
Also filed as: KURTOGLU METIN
4 granted patents·7 pending applications·18 citations·filing 2007–2024
71Inventor score
Top patents by PatentIndex Score
11 records- 0194US10934337B2Anti-BCMA chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·8 cites·30 claims
- 0285US11220535B2Anti-BCMA chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2021·Granted Jan 11, 2022·1 cites·30 claims
- 0383US8242167B2Mannose derivatives for killing tumor cellsLAMPIDIS THEODORE J·Filed 2007·Granted Aug 14, 2012·9 cites·17 claims
- 0481US2024294600A1Anti-bcma chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0575US11999773B2Anti-BCMA chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2021·Granted Jun 4, 2024·0 cites·10 claims
- 0661US2024344030A1Multiprotein-engineered cells secreting a multispecific antibodyCARTESIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0759US2011183926A1Treatment using continuous low dose application of sugar analogsUNIV MIAMI·Filed 2009·Application pending·0 cites
- 0852US2023174944A1Engineered cells secreting therapeutic enzymesCARTESIAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0940US2013184330A1Compositions and methods for inducing cancer cell deathLAMPIDIS THEODORE·Filed 2011·Application pending·0 cites
- 1040US2019030073A1Cancer immunotherapy with highly enriched cd8+ chimeric antigen receptor t cellsCARTESIAN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1137US2012070511A1Mitochondrial inhibitors and uses thereofLAMPIDIS THEODORE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →